期刊文献+

乳果糖对临床及亚临床肝性脑病预防作用的实验研究 被引量:7

Experimental Study of Prophylactic Effect of Lactulose on Hepatic Encephalopathy and Sub- clinical Hepatic Encephalopathy
下载PDF
导出
摘要 目的:探讨乳果糖对临床肝性脑病(HE)及亚临床肝性脑病(SHE)的预防作用。方法:实验组和对照组新西兰家兔各8只,于实验前行体感诱发电位(SEP)、脑干听觉诱发电位(BAEP)和动脉血氨水平检查;于0及24h时经耳静脉注射肝毒性药物,并从实验开始起分别喂饲乳果糖和葡萄糖(8h1次)作为HE/SHE的预防性用药,待出现肝功能衰竭后复查SEP、BAEP和动脉血氨水平。结果:出现肝功能衰竭后,实验组家兔SEP N波潜伏期和BAEPⅢ波、Ⅳ波潜伏期及Ⅰ-Ⅲ、 Ⅰ-Ⅳ峰间期较对照组缩短,动脉血氨水平明显下降。结论:乳果糖在急性肝功能衰竭的发生、发展过程中可以起到预防及减轻HE/SHE的作用。 Background/Aims: To discuss the prophylactic effect of lactulose on hepatic encephalopathy (HE) and subclinical hepatic encephalopathy (SHE). Methods: There were 8 New Zealand rabbits in lac- tulose group and control group, respectively. Somatosensory evoked potentials (SEP), brainstem audi- tory evoked potentials (BAEP) and arterial blood ammonia were examined before the study. Liver toxic drug was administered intravenously at 0 and 24 hour. Lactulose or glucose was taken orally every 8 hours after the first intravenous administration for preventing HE/SHE. Evoked potentials and arte- rial blood ammonia were re-examined when the rabbits were in hepatic failure. Results: The latency of SEP N and BAEP Ⅲ,Ⅳ,Ⅰ-Ⅲ,Ⅰ-Ⅳ in the lactulose group was shorter than that in the control group. The arterial blood ammonia level in the lactulose group was lower than that in the control group. Conclusions: HE/SHE can be prevented or mitigated with lactulose during fulminant hepatic failure.
出处 《胃肠病学》 2000年第4期214-215,254,共3页 Chinese Journal of Gastroenterology
关键词 肝性脑病 乳果糖 诱发电位 预防 Hepatic Encephalopathy Lactulose Evoked Potentials
  • 相关文献

参考文献6

  • 1GitlinN.Subclinicalportal-systemicencephalopathy.AmJGastroenterol,1988,83:8~11.
  • 2MeyerKL,DempseyRJ,RoyMW,DonaldsonDL.Somatosensoryevokedpotentialasameasureofexperimentalcerebralischemia.JNeurosurg,1985,62:269~275.
  • 3OttavianiF,PaludettiG,GraossiS,DraicchioF,SantarelliRM,SerafiniG,PettorossiVE.Auditorysteady-stateresponsesintherabbit.Audiology,1990,29:212~218.
  • 4于中麟,钱林学.乳果糖在肝病治疗中的应用[J].中华内科杂志,1996,35(1):65-65. 被引量:37
  • 5BircherJ,MullerJ,GuqqenheimP,HaemmerliUP.Treatmentofchronicportal-systemicencephalopathywithlactulose.Lancet,1966,1:890~892.
  • 6WatanabeA,SakaiT,SatoS,ImaiF,OhtoM,ArakawaY,TodaG,KobayashiK,MutoY,TsujiiT,KawasakiH,OkitaK,TanikawaK,FujiyamaS,ShimadaS.Clinicalefficacyoflactuloseincirrhoticpatientswithandwithoutsubclinicalhepaticencephalopathy.Hepatology,1997,26:1410~1414.

二级参考文献1

共引文献36

同被引文献96

引证文献7

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部